The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (2017)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kex044
PubMed Identifier: 28431104
Publication URI: http://europepmc.org/abstract/MED/28431104
Type: Journal Article/Review
Volume: 56
Parent Publication: Rheumatology (Oxford, England)
Issue: 6
ISSN: 1462-0324